return to news
  1. Upstox
    /
  2. News
    /
  3. Market News
    /
  4. IPO
    /
  5. Q-Line Biotech IPO subscribed 44 times so far on Day 3: Check allotment date and steps

Market News

Q-Line Biotech IPO subscribed 44 times so far on Day 3: Check allotment date and steps

Journalist Kamal Joshi, former Republic TV and latestly editor, now associated with Upstox
By Kamal Joshi

2 min read | Updated on May 25, 2026, 13:37 IST

Google
SelectUpstoxas yourPreferred news source
Copy link
Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Q-Line Biotech IPO: The ₹214.48 crore book-build issue, with a price band of ₹326 to ₹343 per share, is solely a fresh issuance of 62.53 lakh shares, without an offer for sale (OFS) component.

Q-Line Biotech Ltd supplies diagnostic equipment and IVD products for various diagnostic healthcare needs. | Image: LinkedIn/Q-Line Biotech

Q-Line Biotech Ltd supplies diagnostic equipment and IVD products for various diagnostic healthcare needs. | Image: LinkedIn/Q-Line Biotech

Q-Line Biotech IPO: The initial public offering of healthcare solutions provider Q-Line Biotech has been subscribed 44.06 times so far on Monday, May 25, the final day of bidding.

Open FREE Demat Account within minutes!
Join now

It has received bids for 19,70,29,200 shares, compared with 44,72,000 shares on offer, according to the NSE website until 1:37 pm.

The ₹214.48 crore book-build issue, with a price band of ₹326 to ₹343 per share, is solely a fresh issuance of 62.53 lakh shares, without an offer for sale (OFS) component.

The funds generated will be utilised for working capital needs, debt clearance and corporate general purposes.

A lot consists of 400 shares, and the minimum investment for an individual investor is 800 shares. 

The company is engaged in developing, manufacturing and marketing reagents (including kits and POC devices) and consumables and making and supplying diagnostic equipment for various diagnostic healthcare needs.

Q-Line Biotech IPO: Allotment and listing date

Q-Line Biotech IPO allotment status is expected to be finalised on May 26, while listing on the NSE SME platform, Emerge, is likely to take place on May 29.
Upcoming IPOs: Dhoot Transmission files updated DRHP; Cotec Healthcare, Deepa Jewellers get SEBI's approval to launch issues

How to check Q-Line Biotech IPO allotment status on NSE

Steps to check Q-Line Biotech IPO allotment status on Purva Sharegistry India

Q-Line Biotech IPO GMP

According to investorgain.com and media reports, the unlisted shares of Q-Line Biotec are trading at ₹468 per share, reflecting a grey market premium, or GMP, of 36.44% over the upper price band of ₹343.
Disclaimer: Grey Market Premium, or GMP, is an unofficial indicator of market sentiment toward an IPO. It is not regulated by the stock exchanges or SEBI. Upstox neither supports nor encourages grey market trading. Investors are advised to conduct their own research or consult an expert before making any investment decisions.

About The Author

Journalist Kamal Joshi, former Republic TV and latestly editor, now associated with Upstox
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing pickleball, especially flexing his net play. He was previously associated with Republic TV and LatestLY.

Next Story